Llwytho...
Validation of [(18)F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor
BACKGROUND: 3′-Deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) was proposed as an imaging biomarker for the assessment of in vivo cellular proliferation with positron emission tomography (PET). The current study aimed to validate [(18)F]FLT as a perfusion-independent PET tracer, by gaining insight in t...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | EJNMMI Res |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Berlin Heidelberg
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874225/ https://ncbi.nlm.nih.gov/pubmed/29594931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0376-6 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|